Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Cellular and Molecular Life Sciences : CMLS|April 25, 2019
Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platformsMinna Oksanen, Sarka Lehtonen, Merja Jaronen, et al.
Molecular Therapy Oncolytics|July 11, 2018
Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic ImmunotherapyOtto Hemminki, Minna Oksanen, Kristian Taipale, et al.
Molecular Cancer Therapeutics|July 27, 2016
Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive CancerIlkka Liikanen, Siri Tähtinen, Kilian Guse, et al.
Journal of Translational Medicine|August 23, 2013
Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatmentMari Hirvinen, Raita Heiskanen, Minna Oksanen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 11, 2014
Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumorsAnna Kanerva, Anniina Koski, Ilkka Liikanen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 10, 2015
Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and TissuesAnniina Koski, Simona Bramante, Anja Kipar, et al.
Oncoimmunology|May 8, 2015
Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapyIlkka Liikanen, Anniina Koski, Maiju Merisalo-Soikkeli, et al.
Pageof 5